Forward P/S Multiple: sxtchina.com (SXTC)

China SXT Pharmaceuticals (SXTC) is expanding its pharmacy network and modernizing the production of herbal medicines to promote TCM globally. The forward P/S history on the GURU.Markets dynamic chart illustrates these trends, where 0.30 represents the current value of the metric. Success is based on adherence to quality and distribution standards in the PRC, although revenue shortfalls and R&D expenses are creating significant cash flow pressure.
Metric breakdowns and analytics for SXT China (SXTC)

Investment risks in China SXT Pharmaceuticals (SXTC) require analysis via the forward P/S multiple, which strips noise from quotes by comparing the current business value with projected revenue. For a traditional drug manufacturer constrained by government control, this chart reflects the market's real-time assessment of distribution expansion efficiency, allowing investors to determine the asset's fair value considering macroeconomic liquidity and interest rates.